124 related articles for article (PubMed ID: 3159209)
1. Effects of dipyridamole infusion on local platelet aggregation and local formation of thromboxane A2 in patients with pulmonary hypertension.
Gensini GF; Rostagno C; Pezza A; Fanara F; Castellani S; Prisco D; Rogasi PG; Boddi M; Neri Serneri GG
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():257-62. PubMed ID: 3159209
[No Abstract] [Full Text] [Related]
2. Decreased platelet aggregation but increased thromboxane A2 generation in polycythemia vera.
Mehta P; Mehta J; Ross M; Ostrowski N; Player D
Arch Intern Med; 1985 Jul; 145(7):1225-7. PubMed ID: 4015270
[TBL] [Abstract][Full Text] [Related]
3. A dominant role of thromboxane formation in secondary aggregation of platelets.
Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ
Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210
[No Abstract] [Full Text] [Related]
4. Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.
Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
Adv Prostaglandin Thromboxane Res; 1980; 6():187-91. PubMed ID: 7386257
[No Abstract] [Full Text] [Related]
5. Thromboxane A2 in pregnancy and puerperium.
Ylikorkala O; Viinikka L
Br Med J; 1980 Dec; 281(6255):1601-2. PubMed ID: 7448530
[No Abstract] [Full Text] [Related]
6. Thromboxane, prostacyclin, beta-thromboglobin, and diabetes mellitus.
Brunner D; Klinger J; Weisbort J; Tuval M; Nakash J; Rosenberg CH; Nissim S
Clin Ther; 1984; 6(5):636-42. PubMed ID: 6206948
[TBL] [Abstract][Full Text] [Related]
7. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
8. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
Herman AG
Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444
[No Abstract] [Full Text] [Related]
9. Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Lewis GP; Smith JR
Prostaglandins; 1984 Jul; 28(1):29-41. PubMed ID: 6435186
[TBL] [Abstract][Full Text] [Related]
10. A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
Greenwald JE; Wong LK; Rao M; Bianchine JR; Panganamala RV
Biochem Biophys Res Commun; 1978 Oct; 84(4):1112-8. PubMed ID: 728149
[No Abstract] [Full Text] [Related]
11. Warning: platelet factor 4, beta-thromboglobulin and thromboxane in donor's plasma units.
Stratta P; Canavese C; Peiretti F; Vallauri P; Vercellone A
Thromb Haemost; 1983 Feb; 49(1):61. PubMed ID: 6189235
[No Abstract] [Full Text] [Related]
12. Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Rostagno C; Prisco D; Boddi M; Poggesi L
Eur Respir J; 1991 Feb; 4(2):147-51. PubMed ID: 1828437
[TBL] [Abstract][Full Text] [Related]
13. [Changes of platelet aggregation, serum thromboxane and prostacyclin in lung cancer and pulmonary metastatic patients following operation].
Takeda H; Kashimura Y; Takeoka T; Hashimoto M; Tanabe T
Kyobu Geka; 1984 Sep; 37(10):773-7. PubMed ID: 6389949
[No Abstract] [Full Text] [Related]
14. Thromboxane-B2 generation during ex-vivo platelet aggregation.
De Caterina R; Giannessi D; Gazzetti P; Bernini W
J Nucl Med Allied Sci; 1984; 28(3):185-96. PubMed ID: 6530623
[No Abstract] [Full Text] [Related]
15. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.
Zhang X; Ling P
Chin Med J (Engl); 1995 Feb; 108(2):95-7. PubMed ID: 7774397
[TBL] [Abstract][Full Text] [Related]
16. Effects of somatostatin on the behaviour of thromboxane B2 and beta-thromboglobulin in type I diabetes.
Gragnoli G; Signorini AM; Tanganelli I
Acta Endocrinol (Copenh); 1985 May; 109(1):104-7. PubMed ID: 2408435
[TBL] [Abstract][Full Text] [Related]
17. Ethanol and arterial disease.
Mikhailidis DP; Jenkins WJ; Jeremy JY; Barradas MA; Dandona P
N Engl J Med; 1984 Aug; 311(8):537-8. PubMed ID: 6749215
[No Abstract] [Full Text] [Related]
18. Effects of dipyridamole on the hypoxemic pulmonary hypertension of patients with chronic obstructive pulmonary disease.
Nenci GG; Berrettini M; Todisco T; Costantini V; Parise P
Respiration; 1988; 53(1):13-9. PubMed ID: 3387686
[TBL] [Abstract][Full Text] [Related]
19. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
Aushri Z; Berginer V; Nathan I; Dvilansky A
Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
Khimenko PL
Ter Arkh; 1986; 58(5):95-8. PubMed ID: 2874621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
